Furthermore, ICS II significantly improved the functions of learning and memory in Alzheimer's disease (AD) mice and upregulated BDNF/TrkB signaling in paralleled vitro study (Yan et al., 2017; Liu et al., 2018). This evidence concerns the gene BDNF and Alzheimer disease.